Arax Advisory Partners’s ICU Medical ICUI Stock Holding History

Arax Advisory Partners’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$143K	Sell	973 -774	-44%	-$101K	﹤0.01%	2479
2026 Q1	$226K	Sell	1,747 -152	-8%	-$21.8K	0.01%	1028
2025 Q4	$271K	Sell	1,899 -1,513	-44%	-$203K	0.01%	881
2025 Q3	$409K	Buy	3,412 +3,203	+1,533%	+$406K	0.01%	980
2025 Q2	$27.6K	Buy	209 +81	+63%	+$11K	﹤0.01%	1521
2025 Q1	$17.8K	Buy	128 +32	+33%	+$4.97K	﹤0.01%	1351
2024 Q4	$14.9K	Buy	96 +6	+7%	+$1.01K	﹤0.01%	1333
2024 Q3	$16.4K	Buy	90 +33	+58%	+$4.89K	﹤0.01%	1167
2024 Q2	$6.77K	Buy	57 +56	+5,600%	+$5.89K	﹤0.01%	1450
2024 Q1	$108	Hold	1	–	–	﹤0.01%	1286
2023 Q4	$100	Sell	1 -3	-75%	-$293	﹤0.01%	1311
2023 Q3	$477	Hold	4	–	–	﹤0.01%	1243
2023 Q2	$714	Hold	4	–	–	﹤0.01%	1161
2023 Q1	$660	Hold	4	–	–	﹤0.01%	1157
2022 Q4	$630	Hold	4	–	–	﹤0.01%	1143
2022 Q3	$1K	Hold	4	–	–	﹤0.01%	1095
2022 Q2	$1K	Hold	4	–	–	﹤0.01%	1062
2022 Q1	$1K	Buy	4 +1	+33%	+$224	﹤0.01%	1047
2021 Q4	$1K	Buy	+3	New	+$701	﹤0.01%	1028

Other funds holding ICUI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Arax Advisory Partners's ICUI Position: Q2 2026 in Review

Arax Advisory Partners reduced its ICU Medical (ICUI) stake by 44% in Q2 2026, selling an estimated $101K and leaving 973 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #2479.

Arax Advisory Partners first reported a position in ICUI in Q4 2021 and has held it in 19 quarters since. The position peaked at $409K in Q3 2025. 288 funds tracked by Wall St. Rank hold ICUI as of Q2 2026.

Arax Advisory Partners held 973 shares of ICU Medical worth $143K as of Q2 2026.
Arax Advisory Partners sold 774 ICU Medical shares in Q2 2026, an estimated $101K.
ICU Medical made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2479 holding.
Arax Advisory Partners first reported a position in ICU Medical in Q4 2021 and has held it in 19 quarters since.
Arax Advisory Partners's ICU Medical position peaked at $409K in Q3 2025.
288 funds tracked by Wall St. Rank held ICU Medical as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.